These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26795693)

  • 21. Genetic variability of hepatitis B virus and response to antiviral treatments: searching for a bigger picture.
    Yuen LK; Locarnini SA
    J Hepatol; 2009 Mar; 50(3):445-8. PubMed ID: 19152982
    [No Abstract]   [Full Text] [Related]  

  • 22. [Status and progress in chronic hepatitis B cure].
    Zhuang H
    Zhonghua Gan Zang Bing Za Zhi; 2018 Aug; 26(8):561-564. PubMed ID: 30317785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B.
    Lau GK; Cooksley H; Ribeiro RM; Powers KA; Shudo E; Bowden S; Hui CK; Anderson J; Sorbel J; Mondou E; Rousseau F; Lewin S; Perelson AS; Locornini S; Naoumov NV
    Antivir Ther; 2007; 12(5):705-18. PubMed ID: 17713154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting hepatitis B virus cccDNA by CRISPR/Cas9 nuclease efficiently inhibits viral replication.
    Dong C; Qu L; Wang H; Wei L; Dong Y; Xiong S
    Antiviral Res; 2015 Jun; 118():110-7. PubMed ID: 25843425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Entecavir therapy against hepatitis B].
    Kato N; Omata M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():340-4. PubMed ID: 15453342
    [No Abstract]   [Full Text] [Related]  

  • 26. Future therapy for hepatitis B virus infection.
    Minami M
    Clin J Gastroenterol; 2015 Aug; 8(4):167-71. PubMed ID: 26265385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antiviral effects of entecavir in patients with hepatitis B virus-related cirrhosis].
    Xu Y; Wang JB; Xu J; Jiao J; Zhang YG; Ji SW; Zhao P; Guo HH; Li Y; Zhou CY
    Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):109-12. PubMed ID: 20196949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of chronic hepatitis B: focus on telbivudine.
    Lui YY; Chan HL
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):259-68. PubMed ID: 19344240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral chemotherapy for chronic hepatitis B infection: lessons learned from treating HIV-infected patients.
    Locarnini S; Birch C
    J Hepatol; 1999 Mar; 30(3):536-50. PubMed ID: 10190742
    [No Abstract]   [Full Text] [Related]  

  • 30. Chronic hepatitis B virus in young adults: the need for new approaches to management.
    Gill US; Kennedy PT
    Expert Rev Anti Infect Ther; 2014 Sep; 12(9):1045-53. PubMed ID: 25052517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management and prevention of drug resistance in chronic hepatitis B.
    Zoulim F; Durantel D; Deny P
    Liver Int; 2009 Jan; 29 Suppl 1():108-15. PubMed ID: 19207973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral therapy of chronic hepatitis B.
    Zoulim F
    Antiviral Res; 2006 Sep; 71(2-3):206-15. PubMed ID: 16716414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA.
    Ahmed M; Wang F; Levin A; Le C; Eltayebi Y; Houghton M; Tyrrell L; Barakat K
    Drug Discov Today; 2015 May; 20(5):548-61. PubMed ID: 25622780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Events occurring at the time of breakthrough hepatitis during lamivudine treatment for chronic hepatitis B.
    Yokosuka O
    J Gastroenterol; 2004 Aug; 39(8):813-4. PubMed ID: 15338383
    [No Abstract]   [Full Text] [Related]  

  • 35. Novel approaches to new therapies for hepatitis B virus infection.
    Loomba R; Liang TJ
    Antivir Ther; 2006; 11(1):1-15. PubMed ID: 16518955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lamivudine treatment consensus from relative experts in 2003].
    Lamivudine Clinical Practice Group
    Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):497-9. PubMed ID: 12939188
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapy of chronic hepatitis B: new goals and new treatments.
    Mauss S
    Minerva Med; 2009 Dec; 100(6):447-58. PubMed ID: 20010480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is antiviral drug-induced hepatitis B surface antigen loss durable?
    Wong VW; Wong GL; Chan FK
    Gastroenterology; 2014 Dec; 147(6):1435-6. PubMed ID: 25457852
    [No Abstract]   [Full Text] [Related]  

  • 39. How to overcome antiviral-resistant hepatitis B virus?
    Song BC
    Intervirology; 2010; 53(1):29-38. PubMed ID: 20068338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of chronic hepatitis B with a combination of acyclovir and alpha-lymphoblastoid interferon.
    Schalm SW
    J Chemother; 1989 Jul; 1(4 Suppl):1112-4. PubMed ID: 16312795
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.